Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 54

1.

Effectiveness of 7-valent pneumococcal conjugate vaccine in the prevention of invasive pneumococcal disease in children aged 7-59 months. A matched case-control study.

Domínguez A, Ciruela P, García-García JJ, Moraga F, de Sevilla MF, Selva L, Coll F, Muñoz-Almagro C, Planes AM, Codina G, Jordán I, Esteva C, Hernández S, Soldevila N, Cardeñosa N, Batalla J, Salleras L.

Vaccine. 2011 Nov 8;29(48):9020-5. doi: 10.1016/j.vaccine.2011.09.034. Epub 2011 Sep 20.

PMID:
21939724
[PubMed - indexed for MEDLINE]
2.

Modeling the decline in pneumococcal acute otitis media following the introduction of pneumococcal conjugate vaccines in the US.

Shea KM, Weycker D, Stevenson AE, Strutton DR, Pelton SI.

Vaccine. 2011 Oct 19;29(45):8042-8. doi: 10.1016/j.vaccine.2011.08.057. Epub 2011 Aug 24.

PMID:
21871518
[PubMed - indexed for MEDLINE]
3.

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study.

Miller E, Andrews NJ, Waight PA, Slack MP, George RC.

Lancet Infect Dis. 2011 Oct;11(10):760-8. doi: 10.1016/S1473-3099(11)70090-1. Epub 2011 May 27.

PMID:
21621466
[PubMed - indexed for MEDLINE]
4.

Long term trends introduce a potential bias when evaluating the impact of the pneumococcal conjugate vaccination programme in England and Wales.

Flasche S, Slack M, Miller E.

Euro Surveill. 2011 May 19;16(20):19868.

PMID:
21616047
[PubMed - indexed for MEDLINE]
Free Article
5.

Pneumococcal vaccination in children at risk of developing recurrent acute otitis media - a randomized study.

Gisselsson-Solén M, Melhus A, Hermansson A.

Acta Paediatr. 2011 Oct;100(10):1354-8. doi: 10.1111/j.1651-2227.2011.02332.x. Epub 2011 May 27.

PMID:
21517964
[PubMed - indexed for MEDLINE]
6.

Impact of conjugate 7-valent vaccination in Belgium: addressing methodological challenges.

Hanquet G, Lernout T, Vergison A, Verhaegen J, Kissling E, Tuerlinckx D, Malfroot A, Swennen B, Sabbe M; Belgian IPD Scientific Committee.

Vaccine. 2011 Apr 5;29(16):2856-64. doi: 10.1016/j.vaccine.2011.02.016. Epub 2011 Feb 19.

PMID:
21342667
[PubMed - indexed for MEDLINE]
7.

The impact of the heptavalent pneumococcal conjugate vaccine on the epidemiology of acute otitis media complicated by otorrhea.

Stamboulidis K, Chatzaki D, Poulakou G, Ioannidou S, Lebessi E, Katsarolis I, Sypsa V, Tsakanikos M, Kafetzis D, Tsolia MN.

Pediatr Infect Dis J. 2011 Jul;30(7):551-5. doi: 10.1097/INF.0b013e31821038d9.

PMID:
21297521
[PubMed - indexed for MEDLINE]
8.

Smoke-free households with children and decreasing rates of paediatric clinical encounters for otitis media in the United States.

Alpert HR, Behm I, Connolly GN, Kabir Z.

Tob Control. 2011 May;20(3):207-11. doi: 10.1136/tc.2010.038711. Epub 2011 Jan 26.

PMID:
21270071
[PubMed - indexed for MEDLINE]
9.

A placebo-controlled trial of antimicrobial treatment for acute otitis media.

Tähtinen PA, Laine MK, Huovinen P, Jalava J, Ruuskanen O, Ruohola A.

N Engl J Med. 2011 Jan 13;364(2):116-26. doi: 10.1056/NEJMoa1007174.

PMID:
21226577
[PubMed - indexed for MEDLINE]
Free Article
10.

Treatment of acute otitis media in children under 2 years of age.

Hoberman A, Paradise JL, Rockette HE, Shaikh N, Wald ER, Kearney DH, Colborn DK, Kurs-Lasky M, Bhatnagar S, Haralam MA, Zoffel LM, Jenkins C, Pope MA, Balentine TL, Barbadora KA.

N Engl J Med. 2011 Jan 13;364(2):105-15. doi: 10.1056/NEJMoa0912254.

PMID:
21226576
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine.

Bryant KA, Block SL, Baker SA, Gruber WC, Scott DA; PCV13 Infant Study Group.

Pediatrics. 2010 May;125(5):866-75. doi: 10.1542/peds.2009-1405.

PMID:
20435707
[PubMed - indexed for MEDLINE]
Free Article
12.

A dynamic model of pneumococcal infection in the United States: implications for prevention through vaccination.

Van Effelterre T, Moore MR, Fierens F, Whitney CG, White L, Pelton SI, Hausdorff WP.

Vaccine. 2010 May 7;28(21):3650-60. doi: 10.1016/j.vaccine.2010.03.030. Epub 2010 Mar 30.

PMID:
20359560
[PubMed - indexed for MEDLINE]
13.

Otitis media and its consequences: beyond the earache.

Vergison A, Dagan R, Arguedas A, Bonhoeffer J, Cohen R, Dhooge I, Hoberman A, Liese J, Marchisio P, Palmu AA, Ray GT, Sanders EA, Simões EA, Uhari M, van Eldere J, Pelton SI.

Lancet Infect Dis. 2010 Mar;10(3):195-203. doi: 10.1016/S1473-3099(10)70012-8. Review.

PMID:
20185098
[PubMed - indexed for MEDLINE]
14.

New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine.

Casey JR, Adlowitz DG, Pichichero ME.

Pediatr Infect Dis J. 2010 Apr;29(4):304-9. doi: 10.1097/INF.0b013e3181c1bc48.

PMID:
19935445
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Influenza vaccination coverage among children aged 6-23 months - United States, 2007-08 influenza season.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 Oct 2;58(38):1063-6.

PMID:
19798019
[PubMed - indexed for MEDLINE]
Free Article
16.

Reduced physician claims for otitis media after implementation of pneumococcal conjugate vaccine program in the province of Quebec, Canada.

Wals PD, Carbon M, Sévin E, Deceuninck G, Ouakki M.

Pediatr Infect Dis J. 2009 Sep;28(9):e271-5. doi: 10.1097/INF.0b013e3181bad212.

PMID:
19710582
[PubMed - indexed for MEDLINE]
17.

Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings.

Grijalva CG, Nuorti JP, Griffin MR.

JAMA. 2009 Aug 19;302(7):758-66. doi: 10.1001/jama.2009.1163.

PMID:
19690308
[PubMed - indexed for MEDLINE]
18.

Pneumococcal conjugate vaccines for preventing otitis media.

Jansen AG, Hak E, Veenhoven RH, Damoiseaux RA, Schilder AG, Sanders EA.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD001480. doi: 10.1002/14651858.CD001480.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;4:CD001480.

PMID:
19370566
[PubMed - indexed for MEDLINE]
19.

How to compare the efficacy of conjugate vaccines to prevent acute otitis media?

De Wals P, Erickson L, Poirier B, Pépin J, Pichichero ME.

Vaccine. 2009 May 11;27(21):2877-83. doi: 10.1016/j.vaccine.2009.02.102. Epub 2009 Mar 10. Review.

PMID:
19366579
[PubMed - indexed for MEDLINE]
20.

Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.

Vesikari T, Wysocki J, Chevallier B, Karvonen A, Czajka H, Arsène JP, Lommel P, Dieussaert I, Schuerman L.

Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S66-76. doi: 10.1097/INF.0b013e318199f8ef.

PMID:
19325449
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk